Sawai Sets Upsher-Smith $50m+ Target For Former Reddy’s Brands

 
• By Aidan Fry

Sawai believes the Zembrace and Tosymra sumatriptan brands acquired by its US operation Upsher-Smith could within the next three years bring in more than $50m in annual sales.

50M
Sawai Believes Its Upsher-Smith Unit In The US Could More than Double Annual Sales Of Two Sumatriptan Brands Acquired For Dr Reddy's To More Than $50m • Source: Shutterstock

More from Value Added Medicines

More from Products